Viking Global Investors LP Standard Biotools Inc. Transaction History
Viking Global Investors LP
- $25.8 Billion
- Q3 2024
A detailed history of Viking Global Investors LP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 58,651,170 shares of LAB stock, worth $116 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
58,651,170
Previous 58,651,170
-0.0%
Holding current value
$116 Million
Previous $104 Million
9.04%
% of portfolio
0.44%
Previous 0.41%
Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
142Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$141 Million10.68% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$43.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$34.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$30.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.9.58MShares$19 Million0.01% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $156M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...